M.D. Turned VC Beth Seidenberg To Talk Biotech Startups At Disrupt SF
June 23, 2015 at 11:47 AM EDT
Beth Seidenberg is a licensed physician immunologist who helped bring drugs like the asthma drug Singulair and the pain medication Vioxx to market before turning to venture capitalism. As a partner at Kleiner Perkins Caufield & Byers (KPCB), she’s helped develop companies that led to some pretty sizable exits, and we’re thrilled to announce that Seidenberg will be talking with… Read More
